| 產(chǎn)品名稱 | 
      Human rhinovirus 95 | 
    
    
      | 商品貨號(hào) | 
      B162867 | 
    
      
      | Classification | 
      Picornaviridae, Rhinovirus, Human rhinovirus A | 
    
      
      | Deposited As | 
      Rhinovirus type 95 | 
    
      
      | Agent | 
      Human rhinovirus 95 | 
    
      
      | Strain | 
      SF-998 | 
    
      
      | Applications | 
      Respiratory research  | 
    
      
      | Biosafety Level | 
      2 
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.   | 
    
      
      | Isolation | 
      Upper respiratory tract  | 
    
      
      | Product Format | 
      frozen | 
    
      
      | Storage Conditions | 
      -70°C or colder | 
    
      
      | Comments | 
      Does not cross-react with other recognized rhinoviruses.  Grown in HeLa cells orginally contaminated with Mycoplasma orale and then cured. Does not cross-react with other recognized rhinoviruses. Grown in HeLa cells orginally contaminated with Mycoplasma orale and then cured.  | 
    
      
      | Effect on Host | 
      Yes, in vitro effects: Cytopathic effects (destruction of host cells) Typical rhinovirus CPE in cell culture, including rounding and sloughing of infected cells.  | 
    
      
      | Recommended Host | 
      human fibroblasts Host of Choice: Human fibroblasts. HeLa cells (ATCC CCL-2); human fibroblasts  | 
    
      
      | Growth Conditions | 
      Temperature: 33.0°C  | 
    
      
      | Name of Depositor | 
      VV Hamparian | 
    
      
      | Source | 
      Upper respiratory tract  | 
    
      
      | References | 
      
            Hamparian VV, et al. A collaborative report: rhinoviruses--extension of the numbering system from 89 to 100.  Virology 159: 191-192, 1987. PubMed: 3037780
          |